Literature DB >> 32078857

Association of serum biomarker neurofilament light concentration with post-stroke depression: A preliminary study.

Hongling Zhao1, Menghui Mo1, Cheng Miao1, Lei Li1, Hui Yang1, Yi Liu1, Gang Yang2.   

Abstract

OBJECTIVE: To investigate serum neurofilament light (sNfL) levels in acute ischemic stroke and to assess whether sNfL are related to the severity of disease and a potential prognostic marker of post-stroke depression (PSD) during a 3-month follow-up period.
METHODS: This was a single-center prospective cohort study. The sNfL concentration was measured in baseline samples using the Simoa platform- Single Molecule Array technology. A psychiatrist administered the Structural Clinical Interview for Diagnostic and Statistical Manual IV to all patients and made a diagnosis of PSD 3 months after stroke. The logistic regression was used to examine the association between sNfL and PSD.
RESULTS: In total, 236 ischemic stroke cases were included and finished the follow-up. In the follow-up, 55 patients were defined as PSD, thus the incidence rate was 23.3% (95% confidence intervals [CI]: 17.9%-28.7%). Significant differences were observed between the sNfL levels in patients with PSD (124.8 pg/ml [interquartile range {IQR}: 59.6-159.2]) and in patients without PSD (35.9 pg/ml [IQR: 18.2-60.4]) levels (P < 0.001). After adjusting for age, family history of depression, marital status, National Institutes of Health and Stroke Scale score, C-reactive protein and homocysteine levels, sNfL levels independently predicted the development of post-stroke depression. The crude and adjusted odds ratios [OR] (and 95%CI) of PSD associated with an IQR increase for sNfL were 3.38(2.29, 4.98) and 2.65(1.59, 4.04), respectively. According to receiver operating characteristic curves (ROC) curves, the cut-off value of sNfL to predict PSD was 111.4 pg/ml with an area under the curve (AUC) of 0.84(95% CI, 0.78-0.90) and with the highest sensitivity (61.8%) and specificity (95.4%).
CONCLUSIONS: In this study, elevated level of sNfL is associated with higher risk of 3-month depression in patients with ischemic stroke and makes early diagnoses of depression. The study needs replication to ensure the validity of our preliminary results.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Axonal injury; Depression; Ischemic stroke; Neurofilament light

Mesh:

Substances:

Year:  2020        PMID: 32078857     DOI: 10.1016/j.genhosppsych.2020.01.006

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  10 in total

Review 1.  Neuroinflammation in HIV-associated depression: evidence and future perspectives.

Authors:  Arish Mudra Rakshasa-Loots; Heather C Whalley; Jaime H Vera; Simon R Cox
Journal:  Mol Psychiatry       Date:  2022-05-26       Impact factor: 13.437

2.  Temporal Patterning of Neurofilament Light as a Blood-Based Biomarker for Stroke: A Systematic Review and Meta-Analysis.

Authors:  Jasmin D Sanchez; Richard A Martirosian; Katherine T Mun; Davis S Chong; Irene Lorenzo Llorente; Timo Uphaus; Klaus Gröschel; Teresa A Wölfer; Steffen Tiedt; Jason D Hinman
Journal:  Front Neurol       Date:  2022-05-16       Impact factor: 4.086

3.  Urinary Metabolite Signatures for Predicting Elderly Stroke Survivors with Depression.

Authors:  Jin Chen; Yan-Ni Lv; Xiao-Bing Li; Jia-Jun Xiong; Hui-Ting Liang; Liang Xie; Chen-Yi Wan; Yun-Qing Chen; Han-Sen Wang; Pan Liu; He-Qing Zheng
Journal:  Neuropsychiatr Dis Treat       Date:  2021-03-25       Impact factor: 2.570

4.  Serum Neurofilament Light Predicts 6-Month Mental Health Outcomes in a Cohort of Patients With Acute Ischemic Stroke.

Authors:  Duo-Zi Wang; Fu-Qiang Guo; Lei Guo; Shu Yang; Neng-Wei Yu; Jian Wang; Jian-Hong Wang
Journal:  Front Psychiatry       Date:  2022-02-07       Impact factor: 4.157

5.  Elevated Red Blood Cell Distribution Width Levels at Admission Predicts Depression After Acute Ischemic Stroke: A 3-Month Follow-Up Study.

Authors:  Yaqiang Li; Mei Zhang; Chunhui Dong; Min Xue; Jing Li; Guixiang Wu
Journal:  Neuropsychiatr Dis Treat       Date:  2022-03-31       Impact factor: 2.570

6.  Neurofilament Light Chain Is a Novel Biomarker for Major Depression and Related Executive Dysfunction.

Authors:  Mu-Hong Chen; Yu-Li Liu; Hsiang-Wei Kuo; Shih-Jen Tsai; Ju-Wei Hsu; Kai-Lin Huang; Pei-Chi Tu; Ya-Mei Bai
Journal:  Int J Neuropsychopharmacol       Date:  2022-02-11       Impact factor: 5.176

Review 7.  Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Poststroke Depression: A Systematic Review and Meta-Analysis.

Authors:  Shirin Sarejloo; Erfan Abadifard; Zhian Jamal Othman; Fatemeh Zafarani; Monireh Khanzadeh; Saeed Sadigh-Eteghad; Fereshteh Farajdokht; Asghar Mohammadpoorasl; Shokoufeh Khanzadeh
Journal:  Dis Markers       Date:  2022-08-08       Impact factor: 3.464

8.  Study on Biomarkers Related to the Treatment of Post-Stroke Depression and Alternative Medical Treatment Methods.

Authors:  Menghan Li; Ran Ding; Xinming Yang; Dawei Ran
Journal:  Neuropsychiatr Dis Treat       Date:  2022-08-26       Impact factor: 2.989

9.  Elevated monocyte-to-HDL cholesterol ratio predicts post-stroke depression.

Authors:  Yaqiang Li; Mei Zhang; Min Xue; Dalei Liu; Jinglong Sun
Journal:  Front Psychiatry       Date:  2022-07-22       Impact factor: 5.435

10.  Development and Validation of 3-Month Major Post-Stroke Depression Prediction Nomogram After Acute Ischemic Stroke Onset.

Authors:  Zhou Zhu; Suiqiang Zhu; Guo Li; Ping Jing; Guohua Chen; Junhua Mei; Jinfeng Miao; Wenzhe Sun; Yan Lan; Xin Zhao; Xiuli Qiu
Journal:  Clin Interv Aging       Date:  2021-07-24       Impact factor: 4.458

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.